Valuation: Stereotaxis, Inc.

Market Cap 138M 119M 111M 102M 191M 13.22B 194M 1.31B 512M 6.63B 519M 508M 21.92B P/E 2026 *
-6.68x
P/E 2027 * -9.2x
Enterprise Value 138M 119M 111M 102M 191M 13.22B 194M 1.31B 512M 6.63B 519M 508M 21.92B EV / Sales 2026 *
3.91x
EV / Sales 2027 * 2.9x
Free-Float
84.79%
Yield 2026 *
-
Yield 2027 * -
1 day+1.47%
1 week-1.43%
Current month+9.52%
1 month-10.97%
3 months-20.23%
6 months-33.65%
Current year-40.00%
1 week 1.32
Extreme 1.325
1.41
1 month 1.24
Extreme 1.24
1.51
Current year 1.24
Extreme 1.24
2.86
1 year 1.24
Extreme 1.24
3.59
3 years 1.24
Extreme 1.24
3.59
5 years 1.24
Extreme 1.24
7.32
10 years 0.47
Extreme 0.47
10.3
Manager TitleAgeSince
Chief Executive Officer - 2017-02-02
Director of Finance/CFO 57 2019-09-30
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 2005-01-31
Chairman - 2017-02-02
Director/Board Member 71 2016-09-28
Date Insider Type Main position Quantity % Market Cap.
7/1/26 Free

Director

43,103 0.0441%
7/1/26 Free

Director

43,103 0.0441%
7/1/26
DAFNA Capital Management LLC
OtherCompany 0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+1.47%-1.43%-52.08%-10.97% 138M
+4.16%+1.75%+23.13%+15.24% 227B
+5.97%+2.77%-0.33%-15.87% 149B
+1.67%-0.88%-17.00%+39.09% 141B
+3.05%+1.15%-49.87%+3.63% 75.37B
+1.43%-0.83%+16.91%+20.50% 53.19B
-0.35%+2.07%-17.25%-12.38% 51.88B
+4.70%+4.84%+29.39%+30.32% 43.89B
+3.64%-0.07%+39.67%+54.01% 40.86B
+2.74%+3.24%+0.88%+9.16% 33.7B
Average +2.56%+1.09%-2.66%+13.27% 81.51B
Weighted average by Cap. +3.17%+1.31%+2.44%+13.69%

Financials

2026 *2027 *
Net sales 35.33M 30.31M 28.3M 25.97M 48.83M 3.38B 49.63M 334M 131M 1.69B 133M 130M 5.6B 47.67M 40.89M 38.18M 35.03M 65.87M 4.56B 66.96M 451M 176M 2.29B 179M 175M 7.56B
Net income -20.47M -17.56M -16.39M -15.04M -28.28M -1.96B -28.75M -193M -75.75M -981M -76.85M -75.18M -3.24B -15.27M -13.1M -12.23M -11.22M -21.1M -1.46B -21.45M -144M -56.5M -732M -57.32M -56.08M -2.42B
Net Debt - -
Logo Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
131
Date Price Change Volume
26-08-19 US$1.380 +1.47% 752,103
26-08-18 US$1.360 -2.16% 535,480
26-08-17 US$1.390 +0.72% 706,569
26-08-14 US$1.380 0.00% 733,107
26-08-13 US$1.380 -1.43% 451,033
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.380USD
Average target price
3.333USD
Spread / Average Target
+141.55%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STXS Stock